Trisomy 21-Driven Metabolite Alterations Are Linked to Cellular Injuries in Down Syndrome

Researchers established a robust Down syndrome (DS) model harnessing hiPSCs from mosaic DS patients. These hiPSC lines encompassed both those with standard karyotype and those carrying an extra copy of extra copy of chromosome 21, allowing the generation isogenic cell lines with a consistent genetic background.